Atlas Trials

Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Pancreatic Cancer

Clinical trial NCT03236883 · UNKNOWN

Trial details

NCT number
NCT03236883
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Pancreatic Cancer Stage IIIPancreatic Cancer Stage IV
Start date
2016-04-01
Primary completion
2019-04-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.